Wednesday, October 9, 2013
© Copyright 2014
Gwinnett Daily Post
LAWRENCEVILLE — Gwinnett Medical Center has been awarded a grant for a study from the National Institutes of Health in partnership with Johns Hopkins University.
Dr. Michael Stechison, the hospital’s director of neuroscience services, is seeking to expand treatment options for future stroke patients. The study, “Minimally Invasive Surgery + rt-PA for Intracerebral Hemorrhage (ICH) Evacuation (or MISTIE),” explores the use of tPA — a clot-busting drug — delivered through a catheter placed using CT guidance.
“This recognition from NIH and Johns Hopkins further solidifies GMC as a first-rate research institution,” Phil Wolfe, president and CEO of Gwinnett Medical Center, said in a news release. “Further, the research efforts represent our commitment to better health outcomes, and provide the community with a range of options all while supporting our leading physicians.”
Gwinnett Medical Center is one of only 60 study participants internationally and the only participant in Georgia.